John Wiley & Sons (NYSE:WLY – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.47 earnings per share for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.08), Briefing.com reports. John Wiley & Sons had a negative net margin of 10.69% and a positive return on equity of 18.82%. The company had revenue of $403.81 million during the quarter, compared to the consensus estimate of $387.40 million. During the same quarter in the prior year, the business earned $0.27 earnings per share. The firm’s revenue for the quarter was down 10.5% compared to the same quarter last year. John Wiley & Sons updated its FY25 guidance to $3.25-3.60 EPS and its FY 2025 guidance to 3.250-3.600 EPS.
John Wiley & Sons Stock Performance
NYSE:WLY traded down $1.45 during mid-day trading on Friday, hitting $43.21. The stock had a trading volume of 721,012 shares, compared to its average volume of 342,119. The company has a debt-to-equity ratio of 1.04, a quick ratio of 0.49 and a current ratio of 0.52. The company’s 50 day simple moving average is $45.81 and its 200 day simple moving average is $40.24. The stock has a market cap of $2.35 billion, a price-to-earnings ratio of -11.87 and a beta of 0.86. John Wiley & Sons has a twelve month low of $28.83 and a twelve month high of $49.20.
John Wiley & Sons Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, July 25th. Stockholders of record on Tuesday, July 9th were paid a dividend of $0.3525 per share. The ex-dividend date of this dividend was Tuesday, July 9th. This is a positive change from John Wiley & Sons’s previous quarterly dividend of $0.35. This represents a $1.41 annualized dividend and a dividend yield of 3.26%. John Wiley & Sons’s payout ratio is currently -38.74%.
About John Wiley & Sons
John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.
Featured Articles
- Five stocks we like better than John Wiley & Sons
- 3 Monster Growth Stocks to Buy Now
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Top Stocks Investing in 5G Technology
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.